[New therapeutic possibilities in the treatment of hepatitis B].
Horsmans
Y
Y
Service de gastroentérologie, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, Belgique.
D000998:Antiviral Agents / Q000627:therapeutic use*; D002648:Child; D016207:Cytokines / Q000627:therapeutic use; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000628:therapy*; D006801:Humans; D007167:Immunotherapy; D007369:Interferon Inducers / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use*; D011063:Poly A-U / Q000627:therapeutic use; D013947:Thymosin / Q000627:therapeutic use
D000998:Antiviral Agents; D016207:Cytokines; D007369:Interferon Inducers; D016898:Interferon-alpha; D011063:Poly A-U; D013947:Thymosin
Nouvelles possibilités thérapeutiques contre l'hépatite B.